Judge Emmet Sullivan said he will "issue an appropriate decision" as soon as possible on Sanofi-Aventis' request to prevent Novartis' Sandoz unit and partner Momenta Pharmaceuticals from selling their FDA-approved copy of blood thinner Lovenox. Sanofi earlier accused the FDA of failing to ensure that the generic product has the identical active ingredient as the brand-name version.

Full Story:

Related Summaries